Category Archives: BioInformatics

bioinformatics presentation intro By: Robert Ness … Continue reading →

The Center for Computational Biology and Bioinformatics Graduate Student Testimonials HD In the era of Big Data, there are a lot of opportunities for discovery, but there are also many challenges that must be overcome in order to gain insight into biological processes. In this... By: CCBB News … Continue reading →

Understanding Bioinformatics: Finding the Biology in a List of Genes This tutorial uses a crime solving analogy to explain how bioinformatics can be used to find the relevant biology in a list of genes. Topics covered include identifying biological functions,... By: Michael Edwards … Continue reading →

Cambridge, MA (PRWEB) April 10, 2015 Paradigm4, creators of SciDB, a leading scientific database for the bioinformatics industry, is sponsoring a session entitled Accelerating Cancer Informatics at Foundation Medicine using SciDB on April 23, 2015, at the BIO IT World event, Seaport World Trade Center, Boston, Massachusetts. Paradigm4 Co-founder and CEO, Marilyn Matz, will co-present with Dr. Eric Neumann, Vice President, Knowledge Informatics, Foundation Medicine, Inc., and Alex Poliakov, Solutions Architect, also from Paradigm4. Big Data to Knowledge (BD2K) Much can be learned from proper analysis of large sets of genomic data. The presentation will describe a few examples of scalable analytics applied to cancer genomics, and how SciDB-R enables this kind of analytics. Combining statistical analysis with other knowledge discovery tools can help accelerate the transformation of large data sets into biological insights. Details Thursday, April 23, 2015 12:20 to 1 PM Track 11: Cancer Informatics Luncheon BIO IT World Conference The Seaport World Trade Center 200 Seaport Boulevard Boston, Massachusetts. Members of the press receive complimentary attendance by registering here: http://www.healthtech.com/press.aspx. A light lunch will be served. About Paradigm4 Paradigm4 helps accelerate bioinformatics research with SciDBa scalable scientific database management system that helps researchers integrate and analyze data, … Continue reading →

OpenHelix for bioinformatics software training Knowing which tools are available, and learning to use them, can be challenging in genomics. The OpenHelix site connects you to information and software training about bioinformatics resources.... By: OpenHelix … Continue reading →

A bioinformatics pipeline for personalized onco-genomics - Dr. Yussanne Ma - MAR 25, 2015 In this session, WestGrid hosted guest speaker Dr. Yussanne Ma, who leads the bioinformatics group at Canada's Michael Smith Genome Sciences Centre in Vancouver, BC. She discussed the ways... By: WGSeminarSeries … Continue reading →

Released: 2-Apr-2015 9:00 AM EDT Source Newsroom: 23andMe Contact Information Available for logged-in reporters only Newswise Mountain View, Calif. April 2, 2015 23andMe, Inc., the leading personal genetics company, today announced the appointment of Robert Gentleman, Ph.D., as vice president of computational biology. Dr. Gentleman joins 23andMe to focus on the exploration of how the human genetic and trait data in the 23andMe database can be used to identify new therapies for disease. Most recently, Dr. Gentleman served as senior director of bioinformatics and computational biology at Genentech. Dr. Gentleman is a trailblazer in his field, said Andy Page, president, 23andMe. A scientist of his caliber coming to the company speaks volumes about the rigorous scientific foundation 23andMe has built and the unique opportunity our data set provides to identify significant genetic discoveries. In addition to broadly overseeing computational biology activities at the company, Dr. Gentleman will specifically focus on collaborating with Dr. Richard Scheller, 23andMe chief science officer and head of therapeutics. He will work with Dr. Scheller and others to help the newly formed therapeutics group utilize data analytics and theoretical models to identify trends and ultimately advance the drug research and discovery process. My hope is that … Continue reading →

Bioinformatics Unit Bioinformatics Unit. By: Centro de Investigacin Genyo … Continue reading →

Bioinformatics hands on experience published article data reproduced! By: Md. Rezaul Islam … Continue reading →

HILDEN, Germany and REDWOOD CITY, California - - Commercial agreement provides QIAGEN's Ingenuity Variant Analysissolution to sequencing provider's customers, expanding market reach of QIAGEN - Leading software for analysis and interpretation will be offered to next-generation sequencing customers of GATC Biotech as part of its bioinformatics platform - Agreement adds integrated, accurate interpretation of disease-focused genetic data QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a commercial agreement with GATC Biotech to provide GATC clients full access to QIAGEN's Ingenuity Variant Analysis solution for analysis and interpretation of genetic data. GATC is one of Europe's leading providers of DNA and RNA sequencing services to customers worldwide. The access will take the form of interpretation services and direct access to Ingenuity Variant Analysis as a feature of the GATC Biotech's services. Ingenuity Variant Analysis is a powerful bioinformatics platform enabling laboratories to efficiently evaluate data generated by high-throughput next-generation sequencing (NGS) technologies. The QIAGEN software quickly filters genetic variants in a secure, private cloud-based environment to identify variants most likely to cause disease, drawing upon the industry-leading Ingenuity Knowledge Base. Dr. Marcus Benz, Chief Operating Officer of GATC Biotech, commented: "This new commercial agreement with QIAGEN provides our customers … Continue reading →